Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by jdstoxon Oct 01, 2018 10:36pm
150 Views
Post# 28726502

RE:RE:RE:RE:RE:RE:RE:Daily Dump

RE:RE:RE:RE:RE:RE:RE:Daily Dumpobserver said, "JD if this stock goes to 18 dollars without a rollback I will crawl from your front street to your front door with a bottle of rum...

And, observer, on that day, I will get two glasses and you and I will sit right there and drink it. And sing like drunken sailors. 

Obviously, 18 and 4 was a New Year's parlour game. My guess wasn't even the highest. I can't make predictions anymore but I can ask what effective treatment of brain tumours might be worth. It ain't 32 cents.

Herceptin has generated about USD $7 billion per year. That's about USD $19 million per day or about CDN $24 million.

Today's market has set the BTI market cap at about $19 million (CDN), .

The market, today, has valued Bioasis at about $5 million less than one day's sales of Herceptin.

I understand that for some people it ain't funny, but for others, including me, there's just a whole lot of humour in that.

If anybody comes to me trying to make the case to me that "The Market Always Knows!!" then the rest of you might get a kick out of an old buzzard throwing his empty rum bottles at the lout.

jdstox

Bullboard Posts